GlobalData on MSN2mon
Biofrontera stock climbs as drug-device succeeds in Phase III skin cancer trialIn the US, the Ameluz PDT therapy is approved to treat mild to moderate actinic keratoses on the face and scalp. PDT therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results